You are here: Industry Insights > API

News List

C2 Pharma acquires Digoxin API Portfolio from Nobilus Ent to guarantee long-term quality and supply chain security expressbpd
March 20, 2019
A fully redundant supply of Digoxin API from C2 PHARMA will be available via two CMO manufacturing sources at Nobilus in Poland and Laurus Labs in India
EastGate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply pharmpacpeutical-technology
March 20, 2019
EastGate Biotech Corp., a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, entered into a long term strategic alliance with MJ Biopharm (www.mjgroup.c
C2 Pharma Acquires Digoxin API Portfolio contractpharma
March 20, 2019
Secures long-term supply of this complex and essential API.
Orphanion Enters API Deal with LGM Pharma contractpharma
March 20, 2019
Expands global access to its niche API services.
Lupin responds to US FDA’s OAI letter expressbpd
March 15, 2019
Lupin is in the process of sending further updates of its corrective actions to the US FDA and remains hopeful of a positive outcome
FDA moving to 'risk-based' inspections even as valsartan scare adds new wrinkle to oversight fiercepharma
January 31, 2019
FDA inspections of generic drug plants are on the rise and should continue to increase through 2019, Commissioner Scott Gottlieb said this week in a series of tweets.
Prinston Issues Recall of Irbesartan, Irbesartan HCTZ Tablets americanpharmaceuticalreview
January 23, 2019
Prinston Pharmaceutical has initiated a voluntary recall of one lot of Irbesartan and seven lots of Irbesartan HCTZ Tablets to the consumer level due to the detection of trace amount of an unexpected impurity found in ....
Torrent Pharmaceuticals Issues Recall of Losartan Potassium Tablets americanpharmaceuticalreview
December 24, 2018
orrent Pharmaceuticals is voluntarily recalling two lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of.....
Chinese API Market Growing Strongly, CPhI China Assisting Enterprises with the Transformation, Innovation, and Comprehensive Upgrading en-cphi.cn
December 17, 2018
The main business income of API manufacturing in China has reached RMB 499.1 billion, growing by 14.68% year on year; and the export of APIs has reached USD 29.1 billion, growing by 13.7% year on year.
Chinese drugmaker pours $145M into plant with plan to produce innovative biologics fiercepharma
December 06, 2018
A Chinese maker of heparin, APIs and some finished drugs is launching the second phase of its manufacturing plant, investing nearly $150 million as it moves into producing innovative biologic drugs for the Chinese market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page